Nemvaleukin alfa is an investigational engineered fusion protein composed of modified interleukin-2 (IL-2) and the high-affinity IL-2 alpha receptor chain.

One woman's story of literal strength illustrates how ovarian cancer symptoms can be missed—and the lighthearted recovery ...

Interval breast cancer rates have remained consistent over 30 years despite age-based screening, highlighting the need for ...

Treatment with Rina-S showed antitumor activity in heavily pretreated patients with advanced ovarian cancer, according to the ...

BATON ROUGE, La. (WAFB) - In an effort to spread awareness about the disease, the 2025 Geaux Teal Ovarian Cancer Awareness ...

A Waltham company pulled the plug on a Phase 3 cancer trial, while a different Waltham company continued its leadership ...

Mutations in BRCA2 — a gene known to repair damaged DNA and suppress tumor formation — can predict an individuals' predisposition to develop breast cancer, ovarian, prostate, pancreatic, and other ...

Positive azenosertib clinical data demonstrated clinically meaningful results in patients with Cyclin E1+ platinum-resistant ovarian cancer ...

Join WXII in supporting the fight against cancer on Wednesday, March 26, by grabbing lunch or dinner at 29 participating Piedmont Triad Jersey Mike's locations ...

Mutations in BRCA2—a gene known to repair damaged DNA and suppress tumor formation—can predict an individual's predisposition ...

A common blood test for ovarian cancer is more likely to fall short for Black and Native American women, according to a new ...

It is imperative to align strategies that can prevent ovarian cancer while also strengthening support for patients, caregivers, and health systems that are confronted by it,” the researchers wrote.